Creative Medical Technology (NASDAQ:CELZ) Stock Price Crosses Below 50-Day Moving Average of $5.07

Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ)’s stock price crossed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $5.07 and traded as low as $4.55. Creative Medical Technology shares last traded at $4.55, with a volume of 987 shares traded.

Creative Medical Technology Stock Down 3.4 %

The company’s 50 day moving average price is $5.08 and its 200-day moving average price is $4.66.

Creative Medical Technology (NASDAQ:CELZ) last issued its earnings results on Friday, March 22nd. The company reported ($1.21) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($1.13) by ($0.08). Research analysts expect that Creative Medical Technology Holdings, Inc. will post -4.68 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Creative Medical Technology

A hedge fund recently bought a new stake in Creative Medical Technology stock. Aaron Wealth Advisors LLC bought a new stake in shares of Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 16,400 shares of the company’s stock, valued at approximately $85,000. Aaron Wealth Advisors LLC owned 1.21% of Creative Medical Technology as of its most recent SEC filing. Institutional investors own 1.42% of the company’s stock.

Creative Medical Technology Company Profile

Creative Medical Technology Holdings, Inc, a commercial stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; and StemSpine, a regenerative stem cell procedure to treat degenerative disc disease.